Skip to content

LEAD - Lung cancer diagnostic and treatment pathways: a comparison between Culturally and Linguistically Diverse (CALD) and Anglo-Australian patients

LEAD - Lung cancer diagnostic and treatment pathways: a comparison between Culturally and Linguistically Diverse (CALD) and Anglo-Australian patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12617000957392
Acronym
LEAD
Enrollment
1064
Registered
2017-07-04
Start date
2017-05-15
Completion date
2018-12-31
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to compare the diagnostic and treatment pathways between Culturally and Linguistically Diverse (CALD) and Anglo-Australian lung cancer patients. Who is it for? You may be eligible to join this study if you are aged 18 years or above and be diagnosed with primary lung cancer at the study sites within the past month or during the recruitment phase. Study details You will be asked to complete a patient survey and/or have a face-to-face interview with the researcher. We will also ask whether we can access your hospital medical records and contact your GP for medical information related to your cancer diagnosis. Study significance This study will provide important information about the barriers existing along the lung cancer pathway from symptom appraisal to treatment in CALD populations and is essential to any future intervention to improve early diagnosis and treatment for lung cancer.

Interventions

The LEAD project has a mixed-method, observational cohort design. The quantitative arm comprises a patient survey, a review of general practice records, and a case-note analysis of hospital records to collect data relevant to the four time intervals. The qualitative arm comprises interviews with lung cancer patients, general practitioners (GPs) and hospital specialists. Data will be collected once only at the time of data collection and the period of observation in each participant will be from

The LEAD project has a mixed-method, observational cohort design. The quantitative arm comprises a patient survey, a review of general practice records, and a case-note analysis of hospital records to collect data relevant to the four time intervals. The qualitative arm comprises interviews with lung cancer patients, general practitioners (GPs) and hospital specialists. Data will be collected once only at the time of data collection and the period of observation in each participant will be from the patient noticing symptoms to the commencement of first treatment

Sponsors

Monash University
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

The patients need to meet two inclusion criterion: (1) be diagnosed with primary lung cancer at the study sites within the past month or during the recruitment phase, and (2) be CALD or Anglo-Australian patients. CALD patients are those who speak one of the following five languages at home or listing these languages as their preferred language: Greek, Italian, Vietnamese, Arabic and Chinese (including Cantonese and Mandarin). Anglo-Australian patients are those (1) being born in Australia or other major English-speaking countries (Canada, New Zealand, the United Kingdom, and the US), and (2) listing English as their preferred language.

Exclusion criteria

Patients who are pregnant or aged under 18 years will be excluded.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 6, 2026